Dr lal stock price
Dr Lal PathLabs to acquire Delta Ria and Pathology | VCCircle May 30, 2016 · Dr Lal PathLabs, which made a spectacular stock market listing in December 2015, currently boasts of a market cap of Rs 7,813.42 crore. Its shares shot up by 71.69% to Rs 944.30 apiece as on Monday compared with its issue price of Rs 550. Dr Lal Pathlabs (NSE:LALPATHLAB) stock prices, fundamental ... The company was incorporated as ‘Dr. Lal PathLabs Private Limited’, a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana (RoC) on February 14, 1995 at Delhi. Dr Lal Pathlabs News Earnings- Business Standard News | Page 1 Business Standard News: News Earnings : Dr Lal Pathlabs News Earnings, Dr Lal Pathlabs updates and more at Business Standard news. | Page 1 By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
Outlookindia | Dr Lal PathLabs Ltd. | stock & share price ...
Dr Lal Pathlabs Ltd Share Price- Get Dr Lal Pathlabs Ltd Stock/Share prices. Check Dr Lal Pathlabs Ltd's Live BSE/NSE prices with Historic data. Check out latest updates on Dr Lal Pathlabs Ltd Dr Lal Pathlabs Share Price, Dr Lal Pathlabs Stock ... Dr Lal Pathlabs Share/Stock Price, Stock Analysis of Dr Lal Pathlabs, Future Prospects, experts view on buy/sell/hold Dr Lal Pathlabs shares. Also get to know the Latest Financials, News, Research Reports, Recommendations and much more.. Why investors are lining up at Dr Lal PathLabs and ...
2 days ago · 6th-Apr-2020 17:41 Source: BSE. Dr Lal PathLabs - Announcement under Regulation 30 (LODR)-Press Release / Media Release . We wish to inform you that the Company as part of …
TradingView India. View live DR LAL PATHLABS LT chart to track its stock's price action. Find market predictions, LALPATHLAB financials and market news. TradingView India. View live DR LAL PATHLABS LT chart to track its stock's price action.
Mar 27, 2020 · CLSA has maintained buy rating on Dr Lal PathLabs and lowered target price to Rs 1,860 from Rs 2,100. Shares of Dr Lal PathLabs ended up 0.57 per cent at Rs 1,410.10 on Thursday while the BSE Sensex closed 1410.99 points up (+4.94%) at 29,946.77. Dr. Lal Pathlabs Ltd., incorporated in 1995, is a midcap company with a market cap of Rs 11832.06 crore.
Feb 14, 2020 · Dr. Lal PathLabs Ltd. LALPATHLAB Morningstar Rating Rating as of Feb 14, 2020. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Stock Share Price | Get Quote | BSE quote options {{HeaderData[0].msg}} × BSE RSS. RSS stands for Really Simple Syndication. RSS feed is a XML file that provides summaries, including links to the full versions of the content.It is available through RSS feed reader or through some browsers. This is an RSS feed from the Bombay Stock Exchange website. This RSS feeds allow you LALPATHLAB Share Price Target - Dr. Lal Path Labs Ltd. NSE ...
DR LAL PATHLABS LT (LALPATHLAB.NS) Stock Price, Quote ...
3 Feb 2020 The total number of shares traded during the day was 11381 in over 1820 trades. The stock hit an intraday high of Rs. 1845.9 and intraday low of 15 Oct 2018 The stock price of Dr Lal PathLabs rose over 9% in the two weeks following the announcement. The share price rise capped years of sustained DR LAL PATHLABS LT (LALPATHLAB.NS) Stock Price, Quote ...
539524 | Complete Dr. Lal PathLabs Ltd. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. Late Dr. (Major) S.K. Lal, a pioneer in the field of pathology who had been trained in the army and later at IPO Status Public Stock Symbol NSE:LALPATHLAB. Dr. Lal Path Labs Ltd. |. Series: EQ. Symbol: LALPATHLAB; ISIN: INE600L01024; Status: Listed; EQ; Market Tracker. Symbol P/E: 49.48; Sectoral Index P/E: Dr. Lal PathLabs stock or share prices, Live BSE/NSE, F&O Quotes of Dr. Lal PathLabs with historic price charts for NSE / BSE. Get Dr. Lal PathLabs buy sell tips Stockopedia rates Dr. Lal PathLabs as a Balanced High Flyer . StockRank™ Beta. Price performance for LALPATHLAB Unlock LALPATHLAB Revenue